Form 4: STERIS VP Sells Shares After Option Exercise
SEC Form 4
Karen L. Burton, VP & CAO of STERIS plc, exercised stock options and sold shares on August 11, 2025.
Summary
- Karen L. Burton, VP & CAO of STERIS plc, exercised an employee stock option to purchase 7,900 ordinary shares at $114.22 per share on August 11, 2025.
- On the same day, Burton sold 7,900 ordinary shares at a weighted average price of $241.73 per share, with prices ranging from $241.33 to $242.32.
- Following these transactions, Burton beneficially owns 5,994 ordinary shares, including 3,216 restricted shares that will vest over the next few years.
Sentiment
Score: 5
Explanation: Neutral. The filing represents a routine transaction. The sale could be for any number of reasons.
Positives
- The exercise of stock options indicates confidence in the company's future performance at the time the options were granted.
Negatives
- The sale of shares could be interpreted as a lack of confidence in the company's short-term prospects, although it could also be for personal financial reasons.
Future Outlook
NA
Industry Context
Insider trading activity is always closely watched by investors as it can provide signals, though not always reliable, about a company's prospects. It is common for executives to exercise options and sell shares for personal financial planning.
Comparison to Industry Standards
- Comparing STERIS plc's insider trading activity to that of competitors such as Getinge AB and Cantel Medical Corp. (now part of STERIS) can provide context. However, without aggregated data on insider transactions across these companies, direct comparisons are limited.
- Benchmarking against industry averages for executive compensation and stock option grants can also offer insights into whether STERIS plc's practices are in line with peers.
Stakeholder Impact
- Shareholders: The sale of shares by a company executive may cause concern among shareholders.
- Employees: No direct impact on employees is apparent from this filing.
Key Dates
| Date | Description |
|---|---|
| 2019-03 | STERIS plc redomiciled to Ireland, granting the reporting person an option to purchase shares. |
| 2025-08-11 | Date of option exercise and share sale. |
| 2025-08-12 | Date of Form 4 filing. |
| 2025-10-01 | 86 restricted ordinary shares lapse. |
| 2026-06-01 | 340 restricted ordinary shares lapse. |
| 2026-06-02 | 225 restricted ordinary shares lapse. |
| 2026-06-03 | 651 restricted ordinary shares lapse. |
| 2026-06-04 | 306 restricted ordinary shares lapse. |
| 2027-06-03 | 651 restricted ordinary shares lapse. |
| 2027-06-04 | 306 restricted ordinary shares lapse. |
| 2028-05-31 | Expiration date of the employee stock option. |
| 2028-06-05 | 651 restricted ordinary shares lapse. |
Keywords
STERIS plc, insider trading, stock options, Form 4, Karen L. Burton, securities, shares, sale, exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.